{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:23:34Z","timestamp":1792808614412,"version":"4.5.0"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Increasing awareness of cardiac manifestations of sarcoidosis and the widespread availability of advanced imaging tests have led to a tidal wave of interest in a condition that was once considered rare. In this Focused Review, we explore important clinical questions that may confront specialists faced with possible cardiac involvement. In the absence of an ideal reference standard, three main sets of clinical criteria exist: the Japanese Ministry of Health and Welfare, the Heart Rhythm Society, and the World Association for Sarcoidosis and Other Granulomatous Disorders criteria. Once cardiac sarcoidosis is suspected, clinicians should be familiar with the prevalence of the disease in different clinical scenarios. Before obtaining advanced cardiac imaging, electrocardiogram, ambulatory electrocardiogram, echocardiogram, and B-type natriuretic peptide may be useful. The available therapies for cardiac sarcoidosis include immunosuppression, antiarrhythmic medications, heart failure medications, device therapy, ablation therapy, and heart transplantation. Contemporary data suggest that long-term survival in cardiac sarcoidosis is better than previously believed. There is no randomized controlled trial demonstrating benefits of screening, but screening is recommended based on observational data.<\/jats:p>","DOI":"10.1513\/annalsats.201902-119cme","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T14:35:58Z","timestamp":1563546958000},"page":"1341-1350","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":56,"title":["Update in Cardiac Sarcoidosis"],"prefix":"10.1093","volume":"16","author":[{"given":"Manuel L.","family":"Ribeiro Neto","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Jellis","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, and Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emer","family":"Joyce","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Callahan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, and Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Hachamovitch","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, and Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"2026012203403384200_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","article-title":"Statement on sarcoidosis","volume":"160","author":"Hunninghake","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203403384200_bib2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America: analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203403384200_bib3","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203403384200_bib4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"2026012203403384200_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","article-title":"A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy","volume":"150","author":"Ardehali","year":"2005","journal-title":"Am Heart J"},{"key":"2026012203403384200_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurjhf\/hfs206","article-title":"Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure","volume":"15","author":"Yoshida","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012203403384200_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am Heart J"},{"key":"2026012203403384200_bib8","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"key":"2026012203403384200_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10840-018-0410-7","article-title":"The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: a systematic review","volume":"53","author":"Vaidya","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"key":"2026012203403384200_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J Intern Med"},{"key":"2026012203403384200_bib11","first-page":"50","article-title":"Cardiac sarcoidosis-state of the art review","volume":"6","author":"Hulten","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"key":"2026012203403384200_bib12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026012203403384200_bib13","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012203403384200_bib14","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012203403384200_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"2026012203403384200_bib16","doi-asserted-by":"crossref","first-page":"614","DOI":"10.12968\/hmed.2016.77.11.614","article-title":"Accurate diagnosis of cardiac sarcoidosis needs a multidisciplinary approach","volume":"77","author":"Kouranos","year":"2016","journal-title":"Br J Hosp Med (Lond)"},{"key":"2026012203403384200_bib17","doi-asserted-by":"crossref","first-page":"e007408","DOI":"10.1161\/CIRCIMAGING.117.007408","article-title":"Establishing an evidence-based method to diagnose cardiac sarcoidosis: the complementary use of cardiac magnetic resonance imaging and FDG-PET","volume":"11","author":"Miller","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012203403384200_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203403384200_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2026012203403384200_bib20","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"2026012203403384200_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.128.1.30","article-title":"Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"2026012203403384200_bib22","doi-asserted-by":"crossref","first-page":"e4518","DOI":"10.1097\/MD.0000000000004518","article-title":"Prevalence of cardiac sarcoidosis in white population: a case-control study: Proposal for a novel risk index based on commonly available tests","volume":"95","author":"Martusewicz-Boros","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026012203403384200_bib23","doi-asserted-by":"crossref","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J"},{"key":"2026012203403384200_bib24","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/archinte.1997.00440370104011","article-title":"Diagnosis and management of neurological sarcoidosis","volume":"157","author":"Lower","year":"1997","journal-title":"Arch Intern Med"},{"key":"2026012203403384200_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026012203403384200_bib26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026012203403384200_bib27","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.hrthm.2015.08.014","article-title":"Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026012203403384200_bib28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/pace.12277","article-title":"Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia","volume":"37","author":"Nery","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026012203403384200_bib29","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jchf.2017.09.022","article-title":"Verification of heart disease: implications for a new heart transplantation allocation system","volume":"5","author":"Raeisi-Giglou","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026012203403384200_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","article-title":"Cardiac sarcoidosis: a retrospective study of 41 cases","volume":"83","author":"Chapelon-Abric","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2026012203403384200_bib31","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.106.4.1021","article-title":"Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis","volume":"106","author":"Suzuki","year":"1994","journal-title":"Chest"},{"key":"2026012203403384200_bib32","doi-asserted-by":"crossref","first-page":"95.e11","DOI":"10.1016\/j.amjmed.2013.10.003","article-title":"Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring","volume":"127","author":"Barrett P","year":"2014","journal-title":"Am J Med"},{"key":"2026012203403384200_bib33","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1253\/circj.CJ-14-1217","article-title":"Association between basal thinning of interventricular septum and adverse long-term clinical outcomes in patients with cardiac sarcoidosis","volume":"79","author":"Nagano","year":"2015","journal-title":"Circ J"},{"key":"2026012203403384200_bib34","first-page":"533","article-title":"Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis","volume":"192","author":"Kul","year":"2014","journal-title":"Hai"},{"key":"2026012203403384200_bib35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.echo.2015.02.018","article-title":"Myocardial damage detected by two-dimensional speckle-tracking echocardiography in patients with extracardiac sarcoidosis: comparison with magnetic resonance imaging","volume":"28","author":"Orii","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2026012203403384200_bib36","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s00392-016-1004-y","article-title":"Diagnostic value of speckle-tracking echocardiography in confirmed cardiac sarcoidosis","volume":"105","author":"Pizarro","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2026012203403384200_bib37","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/echo.13281","article-title":"Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction","volume":"33","author":"Murtagh","year":"2016","journal-title":"Echocardiography"},{"key":"2026012203403384200_bib38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A multiple biomarker approach in patients with cardiac sarcoidosis","volume":"59","author":"Kiko","year":"2018","journal-title":"Int Heart J"},{"key":"2026012203403384200_bib39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/hrt.2004.058016","article-title":"Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance","volume":"92","author":"Schulz-Menger","year":"2006","journal-title":"Heart"},{"key":"2026012203403384200_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9343(01)00677-5","article-title":"Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging","volume":"110","author":"Shimada","year":"2001","journal-title":"Am J Med"},{"key":"2026012203403384200_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","article-title":"Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping","volume":"189","author":"Crouser","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203403384200_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/RTI.0b013e3182761830","article-title":"Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function","volume":"28","author":"Watanabe","year":"2013","journal-title":"J Thorac Imaging"},{"key":"2026012203403384200_bib43","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026012203403384200_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012203403384200_bib45","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"key":"2026012203403384200_bib46","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","author":"Flores","journal-title":"J Nucl Cardiol"},{"key":"2026012203403384200_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"2026012203403384200_bib48","article-title":"Variances of dietary preparation for suppression of physiological 18F-FDG myocardial uptake in the presence of cardiac sarcoidosis: a systematic review","author":"Atterton-Evans","journal-title":"J Nucl Cardiol"},{"key":"2026012203403384200_bib49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2967\/jnumed.115.166884","article-title":"Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in 18F-FDG PET imaging","volume":"57","author":"Scholtens","year":"2016","journal-title":"J Nucl Med"},{"key":"2026012203403384200_bib50","doi-asserted-by":"crossref","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012203403384200_bib51","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.rmed.2018.09.008","article-title":"Cardiac sarcoidosis: diagnosis confirmation by bronchoalveolar lavage and lung biopsy","volume":"144S","author":"Petek","year":"2018","journal-title":"Respir Med"},{"key":"2026012203403384200_bib52","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol"},{"key":"2026012203403384200_bib53","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026012203403384200_bib54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med"},{"key":"2026012203403384200_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"key":"2026012203403384200_bib56","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"2026012203403384200_bib57","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"2026012203403384200_bib58","first-page":"91","article-title":"Practical eminence and experience-based recommendations for use of TNF-\u03b1 inhibitors in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012203403384200_bib59","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s10067-007-0614-1","article-title":"Cardiac sarcoidosis responding to monotherapy with infliximab","volume":"26","author":"Uthman","year":"2007","journal-title":"Clin Rheumatol"},{"key":"2026012203403384200_bib60","first-page":"509","article-title":"Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases","volume":"33","author":"Chapelon-Abric","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2026012203403384200_bib61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/CIR.0b013e318276ce9b","article-title":"2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"127","author":"Epstein","year":"2013","journal-title":"Circulation"},{"key":"2026012203403384200_bib62","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"2026012203403384200_bib63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjcard.2018.09.044","article-title":"Effect of cardiac resynchronization therapy on left ventricular remodeling in patients with cardiac sarcoidosis","volume":"123","author":"Patel","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026012203403384200_bib64","first-page":"70","article-title":"Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis","volume":"32","author":"Bandyopadhyay","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012203403384200_bib65","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacep.2018.05.007","article-title":"Outcomes of catheter ablation of ventricular tachycardia based on etiology in nonischemic heart disease: an International Ventricular Tachycardia Ablation Center collaborative study","volume":"4","author":"Vaseghi","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012203403384200_bib66","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/europace\/eux077","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou","year":"2018","journal-title":"Europace"},{"key":"2026012203403384200_bib67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2026012203403384200_bib68","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCULATIONAHA.118.034687","article-title":"Ventricular arrhythmias in cardiac sarcoidosis","volume":"138","author":"Okada","year":"2018","journal-title":"Circulation"},{"key":"2026012203403384200_bib69","first-page":"978","article-title":"Invasive hemodynamics and rejection rates in patients with cardiac sarcoidosis after heart transplantation","volume":"34","author":"Rosenthal","year":"2018","journal-title":"Can J Cardiol"},{"key":"2026012203403384200_bib70","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.healun.2015.12.005","article-title":"Insights into biopsy-proven cardiac sarcoidosis in patients with heart failure","volume":"35","author":"Sperry","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2026012203403384200_bib71","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2015.06.021","article-title":"Usefulness of cardiac troponins as markers of early treatment response in cardiac sarcoidosis","volume":"116","author":"Kandolin","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026012203403384200_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026012203403384200_bib73","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijcard.2016.10.073","article-title":"Early detection of cardiac involvement in sarcoidosis with 2-dimensional speckle-tracking echocardiography","volume":"227","author":"Schouver","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026012203403384200_bib74","doi-asserted-by":"crossref","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012203403384200_bib75","first-page":"50","article-title":"Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis","volume":"28","author":"Isiguzo","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012203403384200_bib76","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"Padala","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026012203403384200_bib77","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012203403384200_bib78","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"key":"2026012203403384200_bib79","article-title":"Recommendations about screening","volume-title":"Users\u2019 guides to the medical literature: a manual for evidence-based clinical practice, 3rd ed","author":"McCaffery","year":"2015"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/11\/1341\/66381658\/annalsats_16_11_1341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/11\/1341\/66381658\/annalsats_16_11_1341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:44:50Z","timestamp":1769071490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/16\/11\/1341\/8423417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":79,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,1]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201902-119cme","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,11,1]]},"assertion":[{"value":"2019-02-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}